Repros Therapeutics, Inc. (RPRX)

[spartex]

Regarding stock movement: I don't think anyone can say with confidence that the recent reversal was due only to David Miller's report. The two presentations last week may have resulted in a mixed reaction (some retail selling), but obviously someone was buying the shares from the 12's down to 9.7's, and throughout the reversal into the mid-10's.

It is nice though to see some interest again in the stock after the bloodletting the past week. ;)